CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Free Cash Flow (Quarterly): -27.56M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -27.56M |
September 30, 2023 | -26.14M |
June 30, 2023 | -25.51M |
March 31, 2023 | 6.236M |
December 31, 2022 | -18.77M |
September 30, 2022 | -17.53M |
June 30, 2022 | -22.56M |
March 31, 2022 | -25.36M |
December 31, 2021 | -14.24M |
September 30, 2021 | -15.41M |
June 30, 2021 | -19.21M |
March 31, 2021 | -20.66M |
December 31, 2020 | -14.82M |
September 30, 2020 | -7.473M |
June 30, 2020 | -7.749M |
March 31, 2020 | -14.71M |
December 31, 2019 | -28.16M |
September 30, 2019 | -23.15M |
June 30, 2019 | -24.34M |
March 31, 2019 | -22.57M |
December 31, 2018 | -20.06M |
September 30, 2018 | -16.09M |
Date | Value |
---|---|
June 30, 2018 | -12.82M |
March 31, 2018 | -6.487M |
December 31, 2017 | -6.072M |
September 30, 2017 | -5.466M |
June 30, 2017 | -5.891M |
March 31, 2017 | -2.203M |
December 31, 2016 | -5.402M |
September 30, 2016 | -5.746M |
June 30, 2016 | -6.107M |
March 31, 2016 | -6.14M |
December 31, 2015 | -5.196M |
September 30, 2015 | -6.66M |
June 30, 2015 | -5.309M |
March 31, 2015 | -6.159M |
December 31, 2014 | -7.472M |
September 30, 2014 | -3.902M |
June 30, 2014 | -4.80M |
March 31, 2014 | -5.043M |
December 31, 2013 | -3.537M |
September 30, 2013 | -0.601M |
June 30, 2013 | -2.161M |
March 31, 2013 | -2.159M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-28.16M
Minimum
Dec 2019
6.236M
Maximum
Mar 2023
-18.27M
Average
-19.21M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
Gilead Sciences Inc | 2.219B |
Assure Holdings Corp | -0.222M |
Societal CDMO Inc (DELISTED) | 0.793M |
AN2 Therapeutics Inc | -17.07M |
Madrigal Pharmaceuticals Inc | -80.97M |